Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.
By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.
The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.
Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.
Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Pharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.
Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.
A blood-based cell-free DNA (cfDNA) test was able to find patients at increased risk of colorectal cancer (CRC), advanced neoplasia, and advanced precancerous lesions.
Chronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.
For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
The study could lead to early diagnosis and treatment of age-related macular degeneration.
A refresher on best interventions for common respiratory disorders in children.
Pharmacists can now showcase their skills within the health care industry by counseling patients and continuing to learn and grow with them.
When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
Is adherence packaging technology a big investment for a community or independent pharmacy?
OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
Clinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.
Rescheduling cannabis empowers pharmacists to lead in patient care by evaluating safety, interactions, and formulations while providing education.
What are some key strategies for keeping your pharmacy thriving in 2025?
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.